ChemoCentryx
CCXI
#3654
Rank
A$5.54 B
Marketcap
A$77.17
Share price
0.00%
Change (1 day)
28.87%
Change (1 year)

EPS for ChemoCentryx (CCXI)

EPS in 2022 (TTM): A-$2.61

According to ChemoCentryx's latest financial reports the company's current EPS (TTM) is A-$2.81. In 2021 the company made an earnings per share (EPS) of A-$2.81 a decrease over its 2020 EPS that were of A-$1.20.

EPS history for ChemoCentryx from 2012 to 2022

Annual EPS

Year EPS Change
2022 (TTM)A-$2.61-6.8%
2021A-$2.81133.33%
2020A-$1.20-16.49%
2019A-$1.4427.63%
2018A-$1.13-305.41%
2017A$0.55-142.53%
2016A-$1.29-19.44%
2015A-$1.60-0%
2014A-$1.6013.68%
2013A-$1.41-16.67%
2012A-$1.69

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$9.91-453.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$1.05-137.57%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$8.69-409.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$25.80-1,019.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$3.50-224.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$1.47-152.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$6.71-339.15%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$4.27-252.24%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
A$0.67-123.81%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel